The present invention is directed to a compound of Formula (I): and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.

 
Web www.patentalert.com

< Salt and polymorphs of a DPPIV inhibitor

< 3,6-Disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists

> Preventive or ameliorating agent for liver disease involving hepatopathy

> Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof

~ 00291